RMDFX — Aspiriant Defensive Allocation Fund
Data updated: 2026-06-11
RMDFX — Aspiriant Defensive Allocation Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. Market-Neutral · $1.06B AUM · 5.15% expense ratio · 18.0% 1-yr return. From SEC regulatory filings.
RMDFX Fund Overview
RMDFX — Aspiriant Defensive Allocation Fund is a US mutual fund managed by Aspiriant Trust, categorised as Market-Neutral. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Aspiriant Trust
- Category: Market-Neutral
- Assets under management: $1.06B
- 1-year return: 18.0%
- Ticker: RMDFX
- SEC CIK: 0001534881
- SEC series ID: S000051603
- Share class ID: C000162347
RMDFX Holdings
Top 10 holdings of Aspiriant Defensive Allocation Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| GMO Benchmark-Free Allocation Fund | 25.94% |
| Wilshire Bridgewater Managed Alpha (Ireland) Fund | 12.58% |
| iShares Gold Trust | 8.79% |
| Lazard Global Investment Funds plc - Lazard Rathmore Alternative Fund | 6.95% |
| Victory Pioneer Multi-Asset Income Fund | 6.63% |
| JPMorgan Global Allocation Fund | 6.19% |
| Eaton Vance Global Macro Absolute Return Advantage Fund | 6.11% |
| Millennium International Ltd. | 6.01% |
| GMO Investments ICAV - GMO Equity Dislocation Investment Fund | 5.78% |
| Elliott Associates LP | 4.34% |
RMDFX Portfolio Allocation
Asset-class allocation of Aspiriant Defensive Allocation Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Other | 97.8% |
| Cash & Equivalents | 2.1% |
RMDFX Performance
Total returns for RMDFX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 3.3% |
| 1 year | 18.0% |
| 3 years (annualised) | 11.4% |
| 5 years (annualised) | 6.3% |
RMDFX Risk Information
Risk metrics for RMDFX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 5.8%
RMDFX Costs and Fees
RMDFX costs about $515 per $10,000 invested per year in fund expenses.
- Net expense ratio: 5.15%
- Gross expense ratio: 5.23%
- Portfolio turnover: 5%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
RMDFX Cashflows
Over the 12 months to 2026-03, Aspiriant Defensive Allocation Fund had net outflows of $31.98M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | $2.38M |
| 2026-02 | $3.57M |
| 2026-01 | $21.90M |
| 2025-12 | −$1.06M |
| 2025-11 | −$4.64M |
| 2025-10 | −$10.48M |
RMDFX Debt Constituents
No individual debt constituents are reported in Aspiriant Defensive Allocation Fund's latest SEC N-PORT filing.
RMDFX Prospectus and SEC Filings
Official Aspiriant Defensive Allocation Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Market-Neutral funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.